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studies in africa
Aim In sub-Saharan Africa, unacceptably high rates of mortality 
amongst women and children continue to persist. The emergence 
of research employing new genomic technologies is advancing 
knowledge on cause of disease. This review aims to identify birth 
cohort studies conducted in sub-Saharan Africa and to consider their 
suitability as a platform to support genetic epidemiological studies. 
Methods A systematic literature review was conducted to identify 
birth cohort studies in sub-Saharan Africa across the following da-
tabases: MEDLINE, EMBASE, AFRO and OPENsigle. A total of 8110 
papers were retrieved. Application of inclusion/exclusion criteria re-
tained only 189 papers, of which 71 met minimum quality criteria 
and were retained for full text analysis. 
Results The search revealed 28 birth cohorts: 14 of which collected 
biological data, 10 collected blood samples and only one study col-
lected DNA for storage. These studies face many methodological 
challenges: notably, high rates of attrition and lack of funding for 
several rounds of study follow up. Population-based ‘biobanks’ have 
emerged as a major approach to harness genomic technologies in 
health research and yet the sub-Saharan African region still awaits 
large scale birth cohort biobanks collecting DNA and associated 
health and lifestyle data. 
Conclusion Investment in this field, together with related endeav-
ours to foster and develop research capacity for these studies, may 
lead to an improved understanding of the determinants of intrauter-
ine growth and development, birth outcomes such as prematurity 
and low birth weight, the links between maternal and infant health, 
survival of infectious diseases in the first years of life, and response 
to vaccines and antibiotic treatment.
The last two decades have seen a dramatic rise in research output in lon-
gitudinal birth cohort studies (Figure 1) (1). Several large quality birth 
cohort studies have been conducted, and are still ongoing, in high income 
countries (2–11). These studies provide useful insight into the develop-
mental, social and environmental exposures that interact in determining 
disease risk (4–6) and they have led to many notable discoveries (7–9). 
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In recent years, large ‘biobank’ studies have emerged as the 
most successful way of harnessing new genomic technolo-
gies, with the aim of providing resources for the future in-
vestigation of the separate and combined effects of genetic, 
environmental and lifestyle factors underlying multifaceted 
human diseases (10). The value of combining epidemio-
logical and genomic data by using large scale cohort study 
design is growing in recognition and studies recruiting 
more than 500 000 participants are already established or 
underway. These studies, such as the UK Biobank (11), 
have focussed mainly on studying the major common dis-
eases of public health importance, amongst adults in the 
developed world.
Many diseases of the poor, which represent the greatest 
health burden in terms of global mortality, have largely 
been neglected from this field of research. In 2008 there 
were an estimated 8.8 million child deaths; 5.97 million 
(68%) were caused by infectious diseases and nearly half 
(4.20 million) of the deaths occurred in Africa (12). Glob-
al child mortality has fallen since 1990, yet the targets out-
lined in the Millennium Development Goals to reduce this 
by two thirds before 2015, are not being met by many 
countries (13). In sub-Saharan African (SSA) countries, 
maternal complications of pregnancy and communicable 
diseases of women and children are still major public 
health concerns, with an unacceptably high burden of mor-
tality (2,12,13).
Figure 1 Number of publications resulting from a search of the ISI 
Web of Science database for any article containing the term ‘birth 
cohort study’ in the past 20 years; no language or other restrictions.
ited. For example, between African and European studies 
different distributions of genetic polymorphism have been 
found which determine genetic susceptibility to both com-
municable disease (eg, malaria, HIV, tuberculosis) and non-
communicable disease (eg, breast and prostate cancer) 
(15). Birth cohort studies conducted in high income coun-
tries fail to represent the conditions in poverty stricken ar-
eas of the world and there is a clear need for broader geo-
graphical representation in this area of research.
The aims of this review were 3-fold:
1.   to provide a systematic review of birth cohort stud-
ies from SSA and discuss some important charac-
teristics of these studies (population size, length of 
study, and follow up frequency);
2.   to examine the methodology of and the data col-
lected from birth cohort studies in SSA;
3.   to offer recommendations on the feasibility and sus-
tainability of support for this area of research based 
on the findings of this review and in the context of 
the existing literature.
METHODS
Search strategy
After initial scoping exercises and input from a librarian to 
provide MeSH headings and keywords pertinent to this 
study, a systematic search was conducted across the follow-
ing databases (Figure 2):
1)   via OVID: Medline (1950 onwards) on 30 July 
2010 and Embase (1980 onwards) on 19 August 
2010, using the strategy outlined in Table 1;
2)   via the Global Health Library Regional Index: 
AFRO on 22 August 2010, using ‘cohort’ as a key-
word;
3)   search of grey literature: via OpenSIGLE on 22 Au-
gust 2010, using ‘birth’ and ‘cohort’ as keywords. 
An informal search of Google Scholar produced no addi-
tional results. 
Reference lists of finally selected papers were hand searched 
for further studies.
The aim of this search was to identify all birth cohort stud-
ies and not necessarily all publications relating to each 
study. 
Inclusion/exclusion criteria
We defined a birth cohort study as a study collecting data 
from a group of people born at a similar time, by active 
(medical examinations etc) and/or passive (hospital re-
cords, etc.) surveillance, with follow up over a variable pe-
riod of time (months to decades) (Table 2). Initial inclusion 
A study by Moran et al (14), at the Institute for Interna-
tional Health in Sydney, observed a marked discrepancy 
between funding for research and development relative to 
disease burden. This mismatch (with very low research in-
vestment relative to disease burden) was most notable for 
bacterial pneumonia and diarrhoea which account for 18% 
and 15% of global child deaths respectively, most of these 
death’s being concentrated in several large developing 
countries in SSA and South East Asia (12). In addition to 
this, the transferability of research findings on determinants 
of disease from high-income countries to SSA may be lim-V
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criteria were sensitive but not specific, so that we could re-
trieve longitudinal studies which, whilst not necessarily 
meeting strict definitions of birth cohort studies, are useful 
in providing an overview of the characteristics of studies 
collecting longitudinal data in infancy/childhood in SSA. 
For more specific birth cohort analysis, strict criteria were 
applied to studies in a follow-up to the initial assessment. 
Studies that met the criteria were retained for full text anal-
ysis in order to focus further on quantitative and qualitative 
aspects of data collection. 
Table 1 Search strategy for Medline and Embase*
Birth cohort
1. (birth* adj3 cohort*).ti,ab.
2. (pregnan* adj3 cohort*).ti,ab.
3. famil* cohort*.ti,ab.
4.   (birth* adj3 longitudinal).ti,ab.
OR
Longitudinal studies
5.   Longitudinal Studies/
6.   cohort* survey*.ti,ab.
7. panel stud*.ti,ab.
8. panel survey*.ti,ab.
AND
Developing countries
  1. exp Developing Countries/
  2.   africa/ or africa, northern/ or algeria/ or egypt/ or libya/ or morocco/ 
or tunisia/ or “africa south of the sahara”/ or africa, central/ or cam-
eroon/ or central african republic/ or chad/ or congo/ or “demo-
cratic republic of the congo”/ or equatorial guinea/ or gabon/ or 
africa, eastern/ or burundi/ or djibouti/ or eritrea/ or ethiopia/ or 
kenya/ or rwanda/ or somalia/ or sudan/ or tanzania/ or uganda/ or 
africa, southern/ or angola/ or botswana/ or lesotho/ or malawi/ or 
mozambique/ or namibia/ or south africa/ or swaziland/ or zambia/ 
or zimbabwe/ or africa, western/ or benin/ or burkina faso/ or cape 
verde/ or cote d’ivoire/ or gambia/ or ghana/ or guinea/ or guinea-
bissau/ or liberia/ or mali/ or mauritania/ or niger/ or nigeria/ or 
senegal/ or sierra leone/ or togo/ or “antigua and barbuda”/ or cuba/ 
or dominica/ or dominican republic/ or grenada/ or guadeloupe/ or 
haiti/ or jamaica/ or “saint kitts and nevis”/ or saint lucia/ or “saint 
vincent and the grenadines”/ or central america/ or belize/ or costa 
rica/ or el salvador/ or guatemala/ or honduras/ or nicaragua/ or 
panama/ or panama canal zone/ or mexico/ or argentina/ or bolivia/ 
or brazil/ or chile/ or colombia/ or ecuador/ or guyana/ or paraguay/ 
or peru/ or suriname/ or uruguay/ or venezuela/ or asia, central/ or 
kazakhstan/ or kyrgyzstan/ or tajikistan/ or turkmenistan/ or uzbeki-
stan/ or cambodia/ or east timor/ or indonesia/ or laos/ or malaysia/ 
or myanmar/ or philippines/ or thailand/ or vietnam/ or asia, west-
ern/ or bangladesh/ or bhutan/ or india/ or sikkim/ or afghanistan/ 
or iran/ or iraq/ or jordan/ or lebanon/ or syria/ or turkey/ or yemen/ 
or nepal/ or pakistan/ or sri lanka/ or exp china/ or korea/ or “dem-
ocratic people’s republic of korea”/ or “republic of korea”/ or mon-
golia/ or albania/ or lithuania/ or bosnia-herzegovina/ or bulgaria/ 
or byelarus/ or “macedonia (republic)”/ or moldova/ or montenegro/ 
or romania/ or russia/ or serbia/ or ukraine/ or yugoslavia/ or exp 
transcaucasia/ or armenia/ or azerbaijan/ or “georgia (republic)”/ or 
comoros/ or madagascar/ or mauritius/ or seychelles/ or fiji/ or 
papua new guinea/ or vanuatu/ or palau/ or samoa/ or tonga/
10. low income countr*.tw.
11. middle income countr*.tw.
12. (low adj2 middle income countr*).tw.
*Within each box all terms were combined with Boolean operator OR. 
Developing countries were those defined by the World Bank list of econ-
omies (July 2010) as low- or middle-income.
Table 2  Inclusion and exclusion criteria for assessing the studies 
relevant to birth cohorts in sub-Saharan Africa
Inclusion criteria Exclusion criteria
Stage 1
•   birth cohort/ longitudinal cohort
or cross sectional study of longitudi-
nal population 
or qualitative review of birth cohort.
•   low and middle income countries
•   reporting primary results
or insight to methodology 
or meta-analysis of studies
Stage 1
•   enrolment at >10 years 
of age
•   primarily a pregnancy 
study limited to birth 
weight follow up
Stage 2
•   country in WHO South Saharan 
African Region
Stage 2 –Quality criteria
•   minimum of 12 months 
of follow up
•   minimum cohort size 
of 500
•   less than 60 months of 
age at induction
Figure 2 Summary of the literature search.
REASONS FOR 
EXCLUSION
quality  See 
inclusion/ 
exclusion 
criteria
study 
type
Not a 
longi-tudi-
nal study
Pregnancy 
cohort
Subjects 
not human
methods/ 
results
No results 
or methods 
reported
Incomplete 
detailing of 
cohort 
study 
population, 
selection or 
follow up*
other Duplicates
Systematic  
review of the 
literature
n = 8110
Titles and  
abstracts 
screened for 
relevance
Excluded
n = 7405
Selected for 
abstract analysis
n = 705
Limited to  
countries in WHO 
SSA region
Excluded
n = 516
Stage 1
124 longitudinal
StudieS in young 
children from SSa
Application  
of further
inclusion/  
exclusion criteria
Excluded
n = 118
Stage 2
Selected for full 
paper review
n = 71
28 birth cohort
studiesV
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Data extraction
Studies included in Stage 1 were extracted to an Excel file 
and analysed by abstract alone. This exercise aimed to pro-
vide background perspective of longitudinal studies in SSA 
rather than provide comprehensive data extraction. Stud-
ies included for full paper review (Stage 2) were assessed 
in full and the data obtained was intended to be compre-
hensive. 
Both qualitative and quantitative data were assessed. Stud-
ies were assessed by categories that included, but were not 
limited to, biological samples (such as blood, DNA and 
urine); anthropometric data; cognitive, psychological and 
other developmental indicators; socioeconomic data; meth-
odological challenges; and attrition.
rESULTS
Abstract analysis of 189 papers produced data from 124 
longitudinal cohort studies (Table 3 and Figure 3) meet-
ing Stage 1 criteria. Abstracts were analysed for basic study 
characteristics (Table 3).
Study characteristics – Stage 1
Study size: The study sizes ranged from 30 to 11,342 par-
ticipants. 79 of the studies recruited 1000 or less partici-
pants and only 27 studies recruited more than 1000 at in-
duction. 59 recruited less than the quality criteria (500 
participants) suggested in this study.
Follow up: 53 studies began data collection either in the 
antenatal period or at birth. The follow up period of par-
ticipants ranged from 3 months to 20 years. The ‘Birth To 
Twenty’ study in South Africa is the longest running, has 
followed the initial cohort for 20 years and is still ongoing. 
The majority of the studies (n = 63), however, followed the 
cohort for 2 years or less. 
Frequency: Frequency of follow up ranged from daily to 
two-yearly. Most abstracts did not report data on follow up 
frequency and full text analysis was needed. 
Methods: 48 studies were identified that followed a spe-
cific population. The large majority of studies identified for 
setting were conducted in the community.
Study characteristics – Stage 2
The study characteristics of the full paper reviews are found 
in Table 4. Analysis of 71 full text publications produced 
data for 28 separate birth cohort studies. All further results 
relate to these 28 studies.
Study size: Of the 28 studies retained for full paper analy-
sis, the median number of participants at induction is 
1272, ranging from 571 to 11 342.
Follow up: Median follow up was 24 months, ranging from 
12 to 216 months. Median frequency of follow up was bi-
monthly, ranging from bi-weekly to five annualy.
Age at induction: The mean age of study participants at 
induction was 17 months.
Biological measurements
Blood: Ten of the studies collected blood from study par-
ticipants (Table 5). A number of these ten studies also took 
other blood samples, including: maternal blood (n = 8), 
cord blood (n = 5), placental blood (n = 3) and blood smears 
Table 3 Characteristics of 124 birth cohort studies in Sub-Saha-
ran Africa (SSA)
CharaCteristiCs
No. of 
studies
Size of study* 0–500 49
501–1000 22
1001–1500 6
1501–2000 6
2001–2500 4
>2500 11
Not reported† 26
Maximum age at 
enrolment (months)
Antenatal-birth 53
0–12 14
13–24 5
25–36 5
37–48 3
49–60 12
>60 10
Not reported† 22
Duration of follow up 
(months)
0–24 64
25–48 13
49–72 7
73–96 1
96–120 3
>120 5
Not reported† 31
Follow up frequency 
(months)
Daily 1
Weekly 5
Monthly 13
2–6 monthly 17
>6 monthly 15
Not reported† 74
Setting Community based 46
Facility based 7
Not reported† 71
Specific population Born to HIV+ mother 19
Malaria endemic area 9
Malnourished/ underweight 6
Intervention population 2
Not specific 76
Other 12
* Sometimes varied between publications.
† Details not presented in abstract.V
I
E
W
P
O
I
N
T
S
P
a
P
E
r
S
50	 June, 2011 •  Vol. 1 No. 1				www.jogh.org
Alasdair Campbell and Igor Rudan
(n = 5). Analysis of samples varied. The most common tests 
performed on samples were ELISA and Western blot for HIV 
status and Giemsa stain for malaria.
DNA: most of the longitudinal studies in SSA did not take 
DNA samples. Five studies collected DNA: 3 were to assess 
HIV status, 1 to detect malaria and only 1 stored DNA. The 
‘Birth to Twenty’ study in South Africa began DNA collec-
tion in 2005 and currently has samples for 2200 partici-
pants.
Other biological samples
Very few other biological samples were taken by studies. 
Thirteen of the 28 studies collected no biological data at all.
Anthropometry: 18 studies detailed methods of anthropo-
metric measurements. The World Health Organisation/ Na-
tional Centre for Health Statistics were the most common-
ly used growth references.
Other data: Only one study measured psychological vari-
ables. Measurement of nutrition, cognitive development, 
socio-economic status and psychological variables most 
frequently used questionnaire based data collection. 
Loss to follow up
Attrition in SSA birth cohorts, measured from induction to 
last follow up, has a median of 28% ranging from 0% to 
72.9%. Attrition rates were as follows: 0 to 10% attrition 
in 4 studies, 11–20% in 1 study, 21–30% in 4 studies, 31–
40% in 3 studies and more than 40% in 4 studies. Twelve 
studies did not clearly report loss to follow up. 
Problems reported by studies leading to high rates of attri-
tion included: high infant mortality rates, family relocation, 
refusal to participate, maternal death, wave attrition (not 
present for one follow up, but return for the next) and fail-
ure of researchers to retrace study individuals.
Efforts to promote successful follow up included: provid-
ing participants with incentives – eg, ‘Birth To Twenty’ pro-
vided participants with basic mobile phones to aid contact; 
the Asembo bay cohort study provided free health clinics 
for all participants and a gift pack containing baby care 
items was given to mothers (this reduced attrition from 
18.9% in 1992 to 7.7% in 1994). The Asembo Bay study 
also provided free medications, immunizations, and trans-
portation to and from the study clinic, which contributed 
to a rate of loss to follow-up of only 4 percent over the first 
18 months of follow up. 
Figure 3 Number of birth cohort studies in Sub-Sahran Africa (SSA) by country. Coloured boxes refer number of 
studies in each country (out of 124 birth cohorts). Blue spots relate to the specific locations of the 28 cohorts 
which met full quality criteria. One paper was not presented due to multiple locations of study site.V
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Table 4 Characteristics of studies included for analysis
RefeRence countRy Location yeaR type of cohoRt 
study
cohoRt  
size at 
enRoLment
maximum age 
at enRoLment
(months)
foLLow up 
(months)
foLLow up 
fRequency
attRition*
(%)
Carme 1984;
Guillo du Bodan 1984 Congo Linzolo 1984† retrospective 1003 birth 60  ‡ ‡
Carme 1992; Carme 1994  Congo Linzolo 1981 retrospective 2424 birth 24 twice ‡
Adjorlolo-Johnson 1994  Cote d’Ivoire Abidjan 1990 prospective 619 birth 3 monthly 4.4
Greenberg 1991 
Democratic 
Republic of 
Congo
Kinshasa  1986 prospective 587 9  18 ‡ 4
Hauspie 1989 
Democratic 
Republic of 
Congo
‡ 1977 prospective 4030 48 48 ‡ ‡
Van Lerberghe 1986 
Democratic 
Republic of 
Congo
Kasongo 1974 prospective 4273 60 12 ‡ 26
Ryder 1994a; 
Ryder 1994b
Democratic 
Republic of 
Congo
Kinshasa  1986 prospective 1091 birth 36 monthly ‡
Alemu 1996; Asefa 1996; Asefa 1998;  
Lesaffre 1999  Ethiopia Jimma 1992 prospective 1563 birth 12 2 monthly 14
Byass 2008  Ethiopia Butajira 1987 prospective 1884 birth 216 monthly/ 
quarterly       ‡
Lindtjorn 1992  Ethiopia Dubluk/ Elka 1989 prospective 828 60 24 2 weekly ‡
Kristensen I 2000  Guinea-Bissau ‡ 1990 prospective 8752 birth 20 ‡ 0†
Fegan 2007  Kenya ‡ 2004 prospective 3500 59 24 yearly ‡
Malhotra 2009  Kenya ‡ 2002 prospective 586 birth 36 6 monthly 34
McElroy 1999; McElroy 2000; McElroy 2001  Kenya Asembo bay 1992 prospective 942§ birth 48 2 weekly 28
Nokes 2004; Ochola 2009  Kenya Kilifi 2002 prospective 635 birth 12 monthly 10
Oomen 1979  Kenya Machakos 1974 prospective 568 60 22 monthly 32
ter Kuile 2003; van Eijk 2002  Kenya Kisumu 1996 prospective 661 0 12 monthly 46
Cohen 1976  Lesotho ‡ 1969 cohort/ cross 
sectional 1317 60 60 ‡ ‡
Maleta 2003  Malawi Lungwena 1995 prospective 767 0 36 monthly 72.9
Chilongozi 2008 
Malawi, 
Tanzania,      
Zambia       
‡ 2001 prospective 2383 0 12 2 monthly 44
Elguero 2005  Senegal ‡ 1989 analysis of two 
birth cohorts 11342 0 24 ‡ ‡
Simondon 1998  Senegal Niakhar 1983
mixed retro-
spective/
prospective
1650 60 120 twice 46.8
Kristensen 2006  South Africa Soweto 2000 prospective 571 0 12 2 weekly 21
Reid 1990  South Africa Prieska 1932 retrospective 1227 0 /birth 
record 48 twice 32.5
Adair 2009; Ellison 2000; Griffiths 2008; 
Heerden 2010; Jones 2008; MacKeown 2000; 
MacKeown 2003 MacKeown 2007; Martorell 
2010; Naicker 2010; Norris 2009; Pedro 2008; 
Richter 1995; Richter 2006; Richter 2007; Sabet 
2009; Sheppard 2009; Steyn 2000; Steyn 2006; 
Thandrayen 2009; Vidulich 2006;  Whati 2005; 
van Yach 1991
South Africa Johannesburg
(Soweto) 1990 prospective 3273
antenatal 
period 
(mother) 
and birth
ongoing yearly 28§
Rayco-Solon 2004  The Gambia West Kiang 1950 retrospective 3981 0 death/ 
oct 97 yearly ‡
Vella 1993; Vella 1994  Uganda Arua 1987 prospective 1072 60 24 ‡ ‡
McDowell 1982  Zambia ‡ 1970 prospective 1342 0 60 6 monthly ‡
PC = prospective cohort, RC = retrospective cohort
*Attrition at last recorded study of initial cohort. Attrition varied by study outcome. 
†Publication year. 
‡Data not reported. 
§ Reporting of study size varies (1570, 942 and 833); 942 reported in first paper, so this value taken. V
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Other factors contributing to successful follow up included 
modern communication systems, close and frequent con-
tact with all study sites for standardisation, short periods 
between phases of data collection and detailed contact in-
formation stored in computerised systems. These mea-
sures, however, were not appropriate or feasible for the 
majority of the studies reviewed.
DISCUSSION
This review examined birth cohort studies in SSA – their 
methodologies and the challenges they face – in light of the 
absence of biobank studies in this region and with a view 
to making recommendations about future plans for this 
area of research. The study clearly shows that, although a 
number of efforts do exist, they evolved in their local set-
tings and they weren’t planned or organized in any system-
atic way. Also, they very rarely (if ever) collect and store 
DNA material and frozen plasma for further genetic and 
biochemical studies.
Study limitations
Attempts to overcome publication bias were made by 
searching for unpublished literature via OpenSIGLE (Sys-
tem for Information on Grey Literature in Europe) an open 
access source of bibliographical references of reports and 
other grey literature produced in Europe until 2005. It is, 
however, possible that some sources of grey literature were 
missed. Only two papers were retrieved in French, and 
none in Portuguese, despite the large Francophone and Lu-
sophone populations in Africa. Although no language re-
strictions were applied, it may suggest the design of the 
search criteria was not optimised to retrieving these studies.
Due to the longitudinal nature of cohort studies large num-
bers of papers are produced, over long periods of time, 
Table 5 An overview of the studies that collected biological samples
RefeRence
BLood sampLe
sampLe anaLysis
fRequency of sampLing
ma-
teRnaL 
BLood
coRd 
BLood
pLa-
centaL 
BLood
off-
spRing 
BLood
pLasma/ 
seRum
BLood 
smeaR fixed ongoing
Adjorlolo-Johnson 1994  Y N N Y serum N
ELISA, western blot, synthetic 
peptide tests, flow cytometry, 
cell counts.
– –
Greenberg 1991 Y Y N Y – Y
Screen for HIV-1 antibodies by 
ELISA, confirmed by Western 
blot. Cord-blood from 64 
randomly selected seropositive 
infants.
12 and 18 months 
of age –
Ryder 1994a; 
Ryder 1994b Y N N Y serum N ELISA, western blot. – –
Malhotra 2009  Y Y Y Y Y Y
Immunoglobulims, antibodies, 
filter for Wuchereria bancrofti 
microfilariae, Hb levels 
(HemoCue). Antigens, mitogens 
and recombinant cytokines.
Birth Six monthly
McElroy 1999; McElroy 2000;   
McElroy 2001  Y Y Y Y plasma Y Hb levels: “hemocue”, 
Microscopy: giemsa Birth
Monthly  
(finger prick)
Two weekly 
(blood film)
Nokes 2004; Ochola 2009  N Y N Y – N ELISA Birth Three monthly
ter Kuile 2003;  
van Eijk 2002  Y N Y Y – Y
Finger prick for HIV test, 
malaria smear, Haemocue 
for hb, serostrip HIV-1/2 and 
Capillus HIV1-HIV2 tests
Pre-inclusion 
(maternal blood), 
pregnancy, 1 month 
post partum
–
Chilongozi 2008 Y N N Y – N
Syphilis screen, ELISA or 
western blot test, complete 
blood count, CD4 cell count, 
plasma viral load.
– –
Adair 2009; Ellison 2000; Griffiths 2008; 
Heerden 2010;  Jones 2008; MacKeown 
2000; MacKeown 2003;  MacKeown 
2007; Martorell 2010; Naicker 2010; 
Norris 2009; Pedro 2008; Richter 1995; 
Richter 2006; Richter 2007; Sabet 2009; 
Sheppard 2009; Steyn 2000; Steyn 2006; 
Thandrayen 2009; Vidulich 2006; Whati 
2005; van Yach 1991 
Y Y N Y – –
Non fasting sample- lipids. 
Lead, glucose, insulin, cotinine, 
HIV status, vit D and bone 
turnover markers.
Birth, 5 years, 
13 years and 14 
years.
Rayco-Solon 2004 N N N Y – Y
TOTAL 8 5 3 10 5
Y – yes, N – noV
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from multiple rounds of study follow up. It is, as a result, 
challenging to capture the most updated description of an 
individual study. Efforts were made to group papers by 
study, both by hand (matching authors, years and sample 
sizes) and citation mapping, in order to identify the most 
recent description of any particular study and to capture 
all the data across the spread of publications arising from 
a single cohort. It is, however, possible that the current sta-
tus of a study was not identified. Study characteristics are 
often reported differently between publications as cohort 
studies continue to develop over time in their methods and 
study sub-populations. It is possible that the conclusions 
of this study about the lack of good biological data collec-
tion reflect unreported data or failure to capture data, rath-
er than a genuine lack of samples. Writing to authors may 
have helped to indentify the most comprehensive and cur-
rent descriptions of birth cohort studies. 
Study quality
Comparability across birth cohort reviews is complicated 
by the different definitions of birth cohort studies. The def-
inition is generally recognised as the longitudinal follow up 
of a group of people born at, or around, the same time. The 
descriptive elements considered important in this review 
include the study size at enrolment, the age of study par-
ticipants at enrolment, the duration of follow up and the 
frequency of these follow ups. This review identified a sub-
group of twenty eight studies that met strict criteria (mini-
mum enrolment of 500 or more study participants with at 
least 12 months of follow up and enrolment at less than 60 
months of age) with a view to identifying studies suitable 
for biobank data collection for the purposes of studying 
important causes of child health and development.
This review demonstrated, first, that the majority of birth 
cohort studies researched a specific sub-population rather 
than representative population samples eg, assessing HIV 
related outcomes in offspring of HIV positive mothers. Sec-
ond, the SSA birth cohorts are largely restricted to small 
sample sizes with short periods of active follow up, with 
sample sizes varying from 571 to 11 342. Only two birth 
cohort studies were identified with study sizes greater than 
5000. The ‘Birth to Twenty’ study in South Africa began 
following an unselected population of 3275 mothers and 
their children in 1990 and is still ongoing today. It is the 
best example of a large scale, long term birth cohort in SSA. 
However, it is of relatively small scale when compared to 
similar birth cohort studies in developed countries such as 
Avon Longitudinal study of Parents and Children (AL-
SPAC) which studied 13 971 births at induction (2). Typi-
cal genome wide association study sizes comprise several 
thousand, or even tens of thousands, of individuals. Rec-
ommended sample sizes for gene-environment interaction 
studies are of the order of twenty thousand participants 
with a specific outcome of interest (16). Small sample siz-
es of the African studies identified in this review are un-
likely to provide a secure basis upon which to study the 
genetic and environmental influences of health and devel-
opment outcomes in pregnancy and early childhood.
Second, the large majority of studies followed the cohort 
for less than two years, an insufficient amount of time on 
which to draw conclusions relating to the long term influ-
ence of developmental factors on future child, adolescent 
and adult health.
Third, the large majority of studies followed the cohort for 
less than two years, an insufficient amount of time on 
which to draw conclusions relating to the long term influ-
ence of developmental factors on future child, adolescent 
and adult health.
Finally, there is no single coordinated definition of a birth 
cohort and measurements vary greatly between different 
studies. It is, therefore, difficult to combine study results 
or conduct meta-analyses of data due to inherent differ-
ences in birth cohort study design and measurement meth-
ods. Efforts have been made to bring together data from 
the largest low and middle income country birth cohorts 
as part of the work of the Consortium of Health Orientated 
Research in Transitioning Societies (COHORTS), but this 
initiative does not include the creation of a large biological 
resource (17). The five largest prospective birth cohorts 
with sample sizes of 2000 or more newborns and at least 
15 years of follow up were included in this initiative and 
the data sets of these studies pooled. Some of the challeng-
es identified by the COHORTS group included differences 
in variable definitions and measurement techniques; dif-
ferent ages for which data are available; and different time 
periods captured by each study. These differences between 
the studies resulted in restriction of their analyses to only 
those variables which were collected consistently across the 
cohorts. These limitations also apply to the SSA studies 
identified in this review.
Biological data
Human genomic studies have revolutionized our under-
standing of disease and rapid progress has been made in 
high income countries with completion of the human ge-
nome project, emergence of genome wide association stud-
ies and the prospect of whole genome sequencing and 
pharmacogenomics (18,19).
Africa, where all human populations originated, is the most 
genetically diverse region in the world. To date, the relative 
risks (or odds ratios) for complex diseases associated with 
genetic loci – studied mainly in high-income countries – 
have been small (1.5 or less) (20). People of African origin 
display shorter linkage disequilibrium (LD) blocks, allow-
ing for more precise mapping of loci associated with disease 
risk and the potential to discover disease causing variants V
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which may previously have been masked by large LD 
blocks in European populations (21,22). Genetic factors 
do not account for chronic disease susceptibility alone, 
rather they interact with environmental exposures to de-
termine disease risk (23). Africa’s genetic diversity, com-
bined with its environmental diversity, unique life expo-
sures and natural selection pressures presents many 
exciting possibilities for genetic research.
This review serves to highlight the lack of systematically 
collected birth cohort data on genetic, environmental and 
lifestyle factors underlying child health and development 
problems of SSA. Only one of the birth cohorts identified 
took DNA samples to establish a DNA bank, and this con-
tained only 2 200 individuals. The majority of DNA sam-
ples taken by studies were one-off measurements for diag-
nostic assessment of HIV or malaria status. The 473 GWA 
articles contained in the National Human Genome Re-
search Institute catalogue were assigned weight according 
to country of origin in a study by Rosenburg et al. (24). 
These comparative weightings showed that the contribu-
tion of sub-Saharan African countries to genome wide as-
sociation studies, even when all SSA country inputs are 
combined (0.34), is insignificant compared to those of high 
income countries (eg, 205.5 in USA, 68.15 in UK and 
37.02 in Germany). 
Overall, 13 of the 28 studies collected no biological sam-
ples of any sort reflecting either a primary interest in alter-
native data collection, or a simple lack of resources, man-
power and laboratory facilities to do so.
The same technologies which are being used in developed 
world biobanks have the potential to generate new knowl-
edge about communicable diseases amongst mothers and 
children in Africa. However, a gaping divide exists in clin-
ical and genomic research capacity between SSA and high-
er income countries (21). DNA based studies require strin-
gent quality criteria for complex processing and storage of 
samples, access to laboratories which are equipped with 
state-of-the-art facilities and run by well trained staff (22). 
The complexity of undertaking these studies could, how-
ever, foster local capacity building and drive innovation for 
new research opportunities and development in SSA.
Genome-based studies in developing countries present im-
portant ethical considerations (25). Valid consent must be 
obtained in a way that ensures an informed and voluntary 
choice can be made by study participants, regardless of 
their level of education and literacy. Protecting the privacy 
of study participants is an essential consideration as GWA 
studies have the potential to reveal stigmatising informa-
tion about an individual or population which may be used 
for harm (26). Due to the lack of large scale genotyping fa-
cilities in most sub-Saharan African countries, samples may 
require storage and export for processing in high income 
countries (27). It is essential that a balance is struck be-
tween protection of study participant’s privacy and the 
need for data sharing and release in research (28). Strict 
guidelines on sample handling and destruction are often 
required limiting the ability for secondary analysis and re-
use of archived samples (29). Obtaining ethical approval 
for genomic research in developing countries is under-
standably a complex and challenging process. However, 
these challenges can be successfully met as the experience 
in malaria research has shown (25). 
Challenges of longitudinal studies  
in low-income countries
Longitudinal studies pose unique methodological challeng-
es to researchers. In birth cohorts two types of sample loss 
are reported: initial non-enrolment and attrition on follow 
up. Both have the potential to cause systematic bias in col-
lection and interpretation of results. In the developing 
world, failure to trace individuals is reported as the most 
common cause of attrition (30). Lack of infrastructure, ad-
ministrative centres, national databases and aids such as 
widespread patient identifiers in SSA pose a challenge to 
data collectors. High rates of migration also pose a challenge 
to longitudinal studies especially as the more educated, ur-
ban section of a cohort may be more likely to migrate, po-
tentially resulting in a sample no longer representative of 
the original population from which it was taken. 
Efforts to overcome attrition have included providing par-
ticipants with incentives to continue with the study, how-
ever, there is a risk of subsequently conditioning the cohort 
such that they are no longer representative of the normal 
population. Other studies have used national census infor-
mation, army enlistment days and systematic searching of 
all homes in the study area to retrace study participants. 
Despite the methodological challenges faced by longitudi-
nal cohorts in the developing world they are achievable and 
studies such as the Pelotas birth cohort in Brazil are testa-
ment to this (31). The study which began in 1982, mea-
suring over 4000 variables for 5914 study participants, is 
one of the largest and longest running birth cohorts in the 
developing world and is still ongoing today. Household 
sampling, army enlistment and the low emigration rate in 
Pelotas limited attrition and follow up in 2005 retraced 
77% of the original cohort. 
Funding
Most birth cohort studies report difficulty in attracting 
funding for initiating studies and then supporting multiple 
rounds of follow up. There is a particular need for multiple 
sources of funding if birth cohort studies are to collect bio-
logical samples for biobank data. The UK Biobank, a cohort 
of 500 000 people with a baseline assessment and 8 year V
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follow up is projected to cost US$ 104 million (€ 72.5 mil-
lion) (32). The UK Biobank was funded by Wellcome Trust 
(the UK’s largest independent medical research charity), the 
Medical Research Council, the Department of Health, the 
Scottish Government, British Heart Foundation, the North-
west Regional Development Agency and others. 
One study estimated that the cost of setting up a ten year 
study similar to the UK Biobank in SSA with additional ex-
posure measurements, intervention trials and research ca-
pacity building – would cost anywhere between, US$ 23.7 
million (€ 16.5 million) for a cohort of 150 000 people 
across three countries or US$ 2.56 billion (€ 1.8 billion) 
for a cohort of 400 000 people across four countries (33). 
The cost per person per year for the UK Biobank estimate 
to US$ 26 (€ 18) compared to US$ 14–644 (€ 9.8–449) 
for a large scale SSA study. Such investments are substan-
tial. They will, however, have a long term effect by revolu-
tionizing the infrastructure, training and future develop-
ment of academic and clinical research in SSA, and may 
subsequently stimulate economic development.
CONCLUSION
This review identified a larger number of relevant studies 
from 28 sites in Africa (34–91). Only one birth cohort 
study which systematically collected DNA samples and re-
lated health data was identified but this was of a small scale. 
Investment in research training, infrastructure and pilot 
studies alongside the creation of ethical frameworks, qual-
ity assessment and locating long term sources of funding 
are just a few of the initial challenges that need to be ad-
dressed to establish and then ensure the sustainability of 
such biobanks in SSA. Governments and not-for-profit 
agencies have made large investments towards funding bio-
banks in high-income countries. We suggest that it is now 
time they turned their resources towards investing in the 
research capacity of SSA, and in doing so, investing in the 
future of mothers and children upon whom a large burden 
of avoidable mortality is centred.
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